Diabetes/Endocrine (Thyroid/Noninsulin agents) Flashcards

1
Q

Anti-Thyroid Foods

A

GOITROGENS

-Broccoli, cauliflower, kale, cabbage, brussel sprouts, cassava, millet, soybeans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Iodine Sources in Diet

A

Common Sources of Dietary Iodine

Cheese
Cows milk
Eggs 
Frozen Yogurt 
Ice Cream
Iodine-containing multivitamins
Iodized table salt 
Saltwater fish 
Seaweed (including kelp, dulce, nori)
Shellfish
Soy milk 
Soy sauce 
Yogurt
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LEVOTHYROXINE (Levothyroid, Levoxyl, Synthroid)

The prototype

THYROID REPLACEMENT DRUGS (Hypothyroidism)

A
  • Synthetic preparation of T4 equivalent to the naturally occurring thyroid hormone
  • MOA: Some of the T4 is converted to T3 and therefore replacement of both T4 and T3 occurs

-Indications for usage:
Hypothyroidism due to any cause; cretinism, myxedema coma, insufficient TSH, TRH, post surgical removal of the thyroid gland, radiation effects, and treatment with anti-thyroid drugs.

  • A/E:
  • In proper dosage, rarely has problems.
  • Too much thyroid results in THYROTOXICOSIS** causing symptoms of hyperthyroidism, especially rapid heart rate, atrial fibrillation, angina, tremors, weight loss, diarrhea.
  • Patient education:
  • **TAKE ON AN EMPTY STOMACH 30-60 MINUTES before breakfast since food interferes with absorption.

DO NOT CHANGE BRAND NAMES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Liothyronine (T3)

A

-works faster, therefore may be used in myxedema, when fast action is needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Nursing Implications for Hypothyroidism:

A
  • Monitor effects
  • Patient teaching
  • Monitor TSH levels every 3 months until regulated, then once a year
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Drugs for Hyperthyroidism:

A
  • Propylthiouracil (PTU)

- Methimazole (Tapazole)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Propylthiouracil (PTU)

A
  • PTU is one of two prototype antithyroid drugs.
  • MOA – inhibits thyroid hormone synthesis & also decreases the conversion of T4 to T3, the active form of thyroid hormone
  • Very short half-life, must be administered 2-3 times a day
  • Usually given to patients in thyrotoxicosis
  • Serious potential A/E;
  • Agranulocytosis
  • PTU can be used in the 1st trimester only if absolutely necessary (otherwise avoid in pregnant women)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Methimazole (Tapazole)

A
  • Safer and more convenient than PTU
  • MOA: prevents oxidation of iodine and incorporation of iodine into tyrosine; inhibits peroxidase, the enzyme that catalyzes the oxidation process.
  • Indications: Sole form of therapy for Graves Disease, Adjunct to radiation therapy, used before surgery for removal of thyroid;
  • Adverse effects: agranulocytosis, contraindicated in pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Oral Hypoglycemic Agents

A
  • Biguanides
  • Sulfonylureas
  • Meglitinides
  • DPP-4 Enzyme Inhibitors
  • Exenatide
  • Liraglutide
  • Thiazolidinedione
  • Alpha-glucosidase enzyme inhibitor
  • SGLT-2 Inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Class: 2nd Generation Sulfonylureas

A
  • Glimepiride
  • Glipizide
  • Glyburide
  • MOA: Lowers blood glucose by stimulating release of insulin from the pancreas; increases sensitivity to insulin at receptor sites; may decrease hepatic glucose production
  • s/e:HYPOGLYCEMIA, WEIGHT GAIN, disulfiram like reaction with alcohol, GI disturbances (#1 S/E), drug/drug interactions with beta-blockers, antifungals, corticosteroids, thiazide diuretics, and cyclic antidepressants

Approved for PREGNANCY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Class: Biguanides

A

Drug Name: METFORMIN (Glucophage)

  • Preferred starting agent for T2DM
  • Approved for use in children 10 years old and greater with T2DM and in pregnancy.
  • MOA: Increases sensitivity to insulin; decreases hepatic production of glucose; decreases intestinal absorption of glucose
  • Decreases amount of insulin needed by T2DM
  • Lowers Basal and postprandial BGs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Biguanides (Metformin) Cont.

A

s/e: diarrhea, decreased appetite, nausea, lactic acidosis; GI effects subside in time but some may not be able to tolerate

***DOES NOT CAUSE HYPOGLYCEMIA; AIDS IN WEIGHT LOSS (nearly perfect drug)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Biguanides (Metformin) Cont…

A
  • Nursing Implications: Don’t use in acutely ill, renal disease, receiving tests involving IV admin of dyes
  • Discontinue drugs several days before and afterwards (48 hours) for dye procedures
  • LACTIC ACIDOSIS: Metformin inhibits mitochondrial oxidation of lactic acid which allows it to build up in the bloodstream. s/s include hyperventilation, myalgia, malaise and unusual sleepiness

Drug interaction: Alcohol and cimetidine (tagamet) can lead to lactic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Class: Thiazolidinediones (Glitazones; TZD’s)

A
  • Pioglitazone (Actos)
  • Rosiglitazone (Avandia)
  • Pioglitazone DECREASES INSULIN RESISTANCE increasing insulin action at receptors and post receptor level in hepatic and peripheral tissue
  • Rosiglitazone only available under a restricted program
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Thiazolidinediones Cont.

A

-a/e: upper respiratory infection, headache, sinusitis, myalgia, FLUID RETENTION (can worsen heart failure is person already has heart failure), HYPOGLYCEMIA

-Nursing Implications:
Monitor for weight gain and /or fluid retention, shortness of breath, chest pain; can be used in mild CHF only

-may decrease effect of oral contraceptives; usually given with insulin or sulfonylurea but can be used as monotherapy; check liver enzymes q 2 months for first year

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Class: Alpha-Glucosidase Enzyme Inhibitors

A

Drugs:

  • Miglitol (glyset)
  • Acarbose (Precose)

–MOA:
delay the breakdown of CHO in the small intestine, thus the rise in postprandial glucose (PPG) is diminished and delayed; They do NOT increase insulin secretion

17
Q

Alpha-Glucosidase Enzyme Inhibitors Cont.

A

Miglitol (glyset) & Acarbose (Precose)

  • May block or reduce weight gain
  • Helpful in reducing postprandial BG
  • s/e: Abdominal pain, flatulence, diarrhea
  • Give 3 times a day before meals
  • Large number of drug/drug interactions
18
Q

Class: Meglitinides (GLINIDES)

A

Drugs:

  • Repaglinide (Prandin)
  • Nateglinide (Starlix)
  • MOA: STIMULATES INSULIN SECRETION via closing or inhibition of ATP-sensitive K channels in beta cells
19
Q

Meglitinides (GLINIDES) cont.

A

-Dosing: take before each meal; medication is very short lived and will stop acting on the beta cells shortly after the meal (1.5 hours half life); should not be given if no meal is consumed.

a/e: hypoglycemia; bronchitis, rhinitis, N/V, diarrhea/constipation, headache, chest pain, UTI’s

-Usually given with metformin; many possible drug/drug interactions that may increase or decrease effects

20
Q

Class: DDP-4 Enzyme Inhibitors (GLIPTINS)

A

Drugs:

  • Sitagliptin (Januvia)
  • MOA: blocks DDP-4 enzyme inhibitors and thereby increases the release of insulin after blood glucose rises (glucose dependent). The inhibitors are GLP-1 and GIP, released by the intestines throughout the day; levels are increased in response to a meal but the hormones are normally quickly deactivated by the enzyme DPP-4 . By giving these drugs more insulin can be released. (Can only be used if the patient is producing normal or elevated levels of insulin).
  • s/e: Less potential for hypoglycemia, headache, pharyngitis, arthritis
21
Q

Class: Sodium-Glucose Co-Transporter 2 (SGLT-2) Inhibitors

A

Drugs:

  • Canagliflozin (Invokana)
  • Dapaglifoxin (Farxiga)

-MOA:
Blocks reabsorption of glucose in the renal tubules. (The transport of glucose from the tubule into the tubular epithelial cells is by means of the sodium glucose co-transporters which accounts for 90% of glucose reabsorption by the kidneys.

22
Q

SGLT-2 Inhibitors Cont..

A

Canagliflozin (Invokana) & Dapaglifoxin (Farxiga)

-A/E:
Most common were female genital fungal infections (due to increased glucose in the urine) , UTI’s, and increased urination. Postural hypotension and dizziness especially in older adults on diuretics. Not indicated in those with GFR < 45 mL/min/1.73 m2.

23
Q

Non-Insulin Injectables for Type 2 DM

*Incretin Mimetics (Injection)

A

Drugs:

  • Exenatide (Byetta)
  • Liraglutide (Victoza)

-MOA:
Activates Receptors for GLP- 1 and thus causes same effects as ENDOGENOUS incretins; Slows gastric emptying, stimulates glucose-depend ent release of insulin, inhibits postprandial release of glucagon, suppresses appetite

-Indications: Adjunctive therapy to improve glucose control in T2DM

24
Q

Incretin Mimetics (Injection)

A
  • Exenatide (Byetta) & Liraglutide (Victoza)
  • a/e: Dose related hypoglycemia especially with a sulfonylurea and; N&V, diarrhea, injection site irritation, pancreatitis, renal impairment, fetal harm (use only if risk outweighs benefit, Category C, ), anaphylaxis, angioedema. Liraglutide may cause thyroid C-cell tumors

-Interactions:
may slow absorption of other oral drugs, especially oral contraceptives and antibiotics, give oral drugs one hour before giving exenatide; Can cause hypoglycemia when taken with alcohol.

comes in prefilled injector pens, 5 or 10 mcg/ml

Give subq before AM and evening meals